Related Experiment Video
Updated: Mar 31, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
Tabular LLMs for Interpretable Few-Shot Alzheimer's Disease Prexdiction with Multimodal Biomedical Data.
Sophie Kearney1, Shu Yang1, Zixuan Wen1
1University of Pennsylvania, Philadelphia, PA, USA.
TAP-GPT, a new AI framework, uses tabular prompts for Alzheimer's disease (AD) prediction. It excels in few-shot learning with incomplete biomarker data, outperforming traditional methods.
Area of Science:
- Artificial Intelligence in Medicine
- Biomedical Informatics
- Computational Neuroscience
Background:
- Accurate Alzheimer's disease (AD) diagnosis relies on tabular biomarker data, which is often small and incomplete.
- Traditional deep learning models struggle with such data, frequently underperforming classical methods.
- Pretrained large language models (LLMs) offer potential for clinical prediction due to their generalization, reasoning, and interpretability.
Purpose of the Study:
- To introduce TAP-GPT, a domain-adapted tabular LLM framework for few-shot Alzheimer's disease classification.
- To evaluate TAP-GPT's performance on multimodal and unimodal AD biomarker datasets.
- To demonstrate the efficacy of tabular LLMs in clinical prediction tasks with limited and incomplete data.
Main Methods:
- Developed TAP-GPT, a framework fine-tuned on TableGPT2 using tabular prompts for AD classification.
- Evaluated TAP-GPT on four ADNI-derived datasets including QT-PAD biomarkers and neuroimaging data (MRI, amyloid PET, tau PET).
- Assessed performance in few-shot settings, comparing against backbone models, traditional machine learning, and general-purpose LLMs, while testing robustness to missing data.
Main Results:
- TAP-GPT improved upon backbone models and outperformed traditional machine learning baselines in few-shot AD classification.
- The framework demonstrated competitive performance with state-of-the-art general-purpose LLMs.
- TAP-GPT maintained stable performance with missing data without imputation and produced interpretable, biology-aligned reasoning.
Conclusions:
- TAP-GPT represents the first systematic application of a tabular-specialized LLM for multimodal biomarker-based AD prediction.
- Domain-adapted tabular LLMs can effectively handle structured clinical prediction tasks, even with incomplete data.
- TAP-GPT lays the groundwork for multi-agent clinical decision-support systems driven by tabular LLMs.
More Related Videos
03:14Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
Published on: December 6, 2024
05:47Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment